Ms. Catherine Flaman reports

ENTOURAGE HEALTH TO REPORT FISCAL YEAR 2023 FINANCIAL RESULTS

Entourage Health Corp. will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended Dec. 31, 2023, after market close on April 29, 2024. The company will defer its fourth quarter and full year 2023 conference call to coincide with its projected first quarter 2024 financial results, expected on or before May 30, 2024. Filing and conference call details for the first quarter of 2024 will be provided in a future announcement.

Company update

The company announced today that, in accordance with the provisions of its omnibus equity incentive compensation plan, the company has authorized the issuance of an aggregate of 1.6 million deferred share units (DSUs) to the board of directors of the company as compensation for their services for the fourth quarter of 2023 and the first quarter of 2024 respectively. The DSUs will vest on Dec. 31, 2024, and March 31, 2025, respectively, and are granted in lieu of cash compensation for services rendered during the quarters.

About Entourage Health Corp.

Entourage Health is the publicly traded parent company of Entourage Brands Corp., a licence holder producing and distributing cannabis products for both the medical and adult-use markets. The company owns and operates a fully licensed, 26,000-square-foot processing facility in Aylmer, Ont. With its Starseed Medicinal medical-centric brand, Entourage has expanded its multichannel distribution strategy. Starseed's industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups, complements Entourage's direct sales to medical patients. Entourage's elite adult-use product portfolio includes Color Cannabis and Saturday Cannabis -- and now Dime Bag and Syndicate -- sold across eight provincial distribution agencies.

We seek Safe Harbor.